Form 4: Amy M. Dodrill Reports Acquisition of Procept BioRobotics Corp Stock and Stock Options

Director Amy M. Dodrill reports acquiring 1,376 shares of common stock and 2,526 stock options in Procept BioRobotics Corp on June 4, 2024.

Summary

• Amy M. Dodrill, a director of Procept BioRobotics Corp, filed a Form 4 on June 6, 2024.
• On June 4, 2024, Dodrill acquired 1,376 shares of common stock in the form of restricted stock units (RSUs) at $0.
• These RSUs vest fully on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting, contingent upon continued service.
• On the same date, Dodrill also acquired 2,526 stock options with an exercise price of $67.29.
• These options also vest fully on the earlier of the one-year anniversary of the grant date or the date of the next annual meeting, contingent upon continued service.
• Following these transactions, Dodrill directly owns 6,088 shares of common stock and 2,526 stock options.

Sentiment

Score: 7

Explanation: The sentiment is neutral to slightly positive. The acquisition of shares and options by a director suggests confidence in the company, but it's a routine transaction.

Positives

• The acquisition of stock and options by a director signals confidence in the company's future performance.

Future Outlook

The vesting of the RSUs and stock options is contingent upon continued service, aligning the director's interests with the company's long-term performance.

Industry Context

Form 4 filings are routine disclosures required by the SEC to ensure transparency in insider trading activities. They provide insights into the actions of company directors and officers, which can be indicative of their confidence in the company's prospects.

Stakeholder Impact

• The acquisition of shares by a director can positively influence shareholder sentiment.

Key Dates